Skip to contentE
Escalon Medical Corp
E
ESMCEscalon Medical Corp Q3 2020 · 10-Q
Revenue$2.36M$2.36M−11.7% vs Q3 2019 Net Income-$127.88K-$127.88KN/M vs Q3 2019 EPS Diluted-$0.02-$0.02— vs Q3 2019 Operating Income-$128,307N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Escalon Medical Corp · CIK 862668 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$462,115N/M Margins · derivedOperating margin-5.4%−6.3 pt vs Q3 2019
Net margin-5.4%−6.3 pt vs Q3 2019
ended Mar 31, 2020 · filed May 14, 2020 · 44 d after period end